Cooper Companies, Inc.
6140 Stoneridge Mall Road
35 articles with Cooper Companies, Inc.
CooperCompanies announced that its Board of Directors elected Teresa S. Madden to the Board as an independent director, effective December 1, 2020.
CooperCompanies announced it will release fourth quarter and full year 2020 financial results on Thursday, December 3, 2020, at 4:15 PM ET.
CooperCompanies and Divisions Named One of Fortune’s Best Large Workplaces in Manufacturing and ProductionCooperCompanies, CooperVision and CooperSurgical All Recognized by Fortune Magazine
CooperCompanies announced that the company, along with its CooperVision and CooperSurgical divisions has been named one of Fortune's Best Large Workplaces in Manufacturing and Production.
CooperCompanies, will participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference, on September 16, 2020.
CooperCompanies, will participate in the 2020 Wells Fargo Virtual Healthcare Conference, on September 10, 2020.
CooperCompanies announced it will release third quarter 2020 financial results on Thursday, September 3, 2020, at 4:15 PM ET.
CooperCompanies, announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on August 7, 2020, to stockholders of record on July 23, 2020.
CooperCompanies Appoints Holly Sheffield as President, CooperSurgical and Announces Robert Auerbach, M.D. to Retire
CooperCompanies announced that Holly Sheffield has been appointed President of CooperSurgical effective July 13, 2020, reporting to Albert White, President and CEO. Ms. Sheffield will succeed Robert Auerbach, M.D. who is retiring.
CooperCompanies announced financial results for the fiscal second quarter ended April 30, 2020.
CooperCompanies announced it will release second quarter 2020 financial results on Thursday, June 4, 2020, at 4:15 PM ET.
CooperCompanies Announces $2.14 Billion Senior Credit Facility and Amendment of $500 Million 364-Day Credit Facility
CooperCompanies announced the closing of a new five-year $2.14 billion senior unsecured credit facility, comprised of a $1.29 billion revolving line of credit and $850 million non-amortizing term loan.
CooperCompanies announced financial results for the fiscal first quarter ended January 31, 2020.
CooperCompanies, will participate in the Oppenheimer 30th Annual Healthcare Conference in New York City, NY, on March 17, 2020.
Signaling a dedication to further strengthen its unique corporate culture, CooperCompanies President and CEO Albert White has signed the CEO Action for Diversity & Inclusion™ pledge.
CooperCompanies, will participate in the Barclays Global Healthcare Conference in Miami, FL, on March 10, 2020.
CooperCompanies Appoints Mark Drury as New Vice President, General Counsel and Corporate Secretary and Announces Randal L. Golden to Retire
CooperCompanies announced that Mark Drury has been appointed Vice President, General Counsel and Corporate Secretary effective February 15, 2020, reporting to Albert G. White, President and Chief Executive Officer.
CooperCompanies announced it will release first quarter 2020 financial results on Thursday, March 5, 2020, at 4:15 PM ET.
CooperCompanies Announces CooperVision Has Received FDA Approval of MiSight® for the Treatment of Myopia in ChildrenBecomes the First and Only FDA Approved Contact Lens of its Kind in the U.S.
CooperCompanies, announced that CooperVision has received U.S. Food and Drug Administration approval of its MiSight® 1 day contact lens1, indicated to slow the progression of myopia when initially prescribed for children 8-12 years old.